Beta-interferons Extend Survival of Relapsing MS Patients, Study Finds
Treatment of relapsing multiple sclerosis (MS) with beta-interferon therapies is associated with extended patient survival, particularly if taking such treatments for more than three years, according to a real-world study in Canada and France. Badanie…